Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Timothy P. CoughlinIndependent Director | -3,25k | 141,34k | Automatic Disposition | 43,49 | 52,25k | -5,86% |
| 2026-05-04 | Dr. William E. RoteChief Research Officer | -2,76k | 121,43k | Derivative Exercise and Sale | 43,95 | 65,87k | - |
| 2026-05-04 | Dr. William E. RoteChief Research Officer | 1,49k | 0,00 | Derivative Exercise and Retained Stock | - | 65,87k | 2,31% |
| 2026-05-04 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -24,25k | 733,46k | Derivative Exercise and Sale | 17,96 - 46,65 | 105,21k | - |
| 2026-05-05 | Dr. Roy D. BaynesIndependent Director | -4,50k | 127,71k | Derivative Exercise and Sale | 18,27 - 46,65 | 37,50k | - |
| 2026-05-04 | Mr. Jeffrey A. MecklerIndependent Director | -8,00k | 229,36k | Derivative Exercise and Sale | 16,33 - 45,00 | 87,50k | - |
| 2026-05-04 | Dr. Eric M. DubePresident, CEO & Director | -22,50k | 988,88k | Derivative Exercise and Sale | 43,95 | 152,37k | - |
| 2026-05-06 | Dr. Jula InrigChief Medical Officer | -311,00 | 13,67k | Automatic Disposition | 43,95 | 113,24k | -0,27% |
| 2026-05-05 | Dr. Jula InrigChief Medical Officer | -2,17k | 101,42k | Verkauf | 46,65 | 113,24k | -1,88% |
| 2026-05-04 | Dr. Jula InrigChief Medical Officer | -20,00k | 452,00k | Derivative Exercise and Sale | 22,40 - 45,00 | 113,24k | - |
| 2026-05-04 | Dr. Jula InrigChief Medical Officer | 4,25k | 0,00 | Derivative Exercise and Retained Stock | - | 113,24k | 3,90% |
| 2026-05-04 | Mr. Christopher ClineCFO | -2,49k | 115,37k | Derivative Exercise and Sale | 43,95 - 46,65 | 118,66k | - |
| 2026-05-04 | Mr. Christopher ClineCFO | 1,76k | 0,00 | Derivative Exercise and Retained Stock | - | 118,66k | 1,50% |
| 2026-05-04 | Mr. Peter HeermaChief Commercial Officer | -2,17k | 101,42k | Derivative Exercise and Sale | 46,65 | 85,05k | - |
| 2026-05-04 | Mr. Peter HeermaChief Commercial Officer | 2,08k | 0,00 | Derivative Exercise and Retained Stock | - | 85,05k | 2,50% |
| 2026-05-01 | Dr. Roy D. BaynesIndependent Director | -9,75k | 364,65k | Derivative Exercise and Sale | 6,82 - 44,22 | 37,50k | - |
| 2026-04-22 | Dr. William E. RoteChief Research Officer | -9,10k | 355,72k | Automatic Disposition | 39,09 | 60,21k | -13,13% |
| 2026-04-14 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -15,25k | 381,52k | Derivative Exercise and Sale | 8,93 - 41,07 | 42,35k | - |
| 2026-04-14 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -6,73k | 276,28k | Automatic Disposition | 41,07 | 42,35k | -13,71% |
| 2026-04-14 | Dr. Roy D. BaynesIndependent Director | -32,75k | 775,82k | Derivative Exercise and Sale | 15,43 - 42,12 | 37,50k | - |
| 2026-04-14 | Mr. Gary A. LyonsIndependent Chairman of the Board | -8,00k | 197,92k | Derivative Exercise and Sale | 16,33 - 41,07 | 57,50k | - |
| 2026-04-14 | Mr. Peter HeermaChief Commercial Officer | -7,22k | 302,52k | Verkauf | 41,93 | 78,80k | -8,39% |
| 2026-04-14 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -37,50k | 874,18k | Derivative Exercise and Sale | 15,46 - 41,07 | 105,21k | - |
| 2026-04-14 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -7,22k | 302,52k | Verkauf | 41,93 | 105,21k | -6,42% |
| 2026-04-15 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -6,79k | 283,81k | Automatic Disposition | 41,62 - 42,53 | 105,21k | -6,06% |
| 2026-04-15 | Dr. Eric M. DubePresident, CEO & Director | -64,00k | 2,63M | Automatic Disposition | 41,01 - 42,66 | 129,71k | -33,04% |
| 2026-04-14 | Dr. Jula InrigChief Medical Officer | -7,22k | 302,52k | Verkauf | 41,93 | 111,47k | -6,08% |
| 2026-04-15 | Dr. Jula InrigChief Medical Officer | -1,02k | 43,38k | Automatic Disposition | 42,61 | 111,47k | -0,90% |
| 2026-04-13 | Mr. Christopher ClineCFO | -7,30k | 305,40k | Verkauf | 28,85 - 41,93 | 116,90k | -5,88% |
| 2026-04-14 | Mr. Christopher ClineCFO | -1,02k | 43,58k | Automatic Disposition | 41,07 - 42,61 | 116,90k | -0,87% |
| 2026-04-06 | Dr. Roy D. BaynesIndependent Director | -10,00k | 64,80k | Derivative Exercise and Sale | 26,52 - 33,00 | 37,50k | - |
| 2026-04-01 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10,00k | 145,40k | Derivative Exercise and Sale | 15,46 - 30,00 | 105,21k | - |
| 2026-04-01 | Dr. Eric M. DubePresident, CEO & Director | -60,00k | 928,24k | Derivative Exercise and Sale | 15,46 - 31,46 | 129,71k | - |
| 2026-03-16 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10,00k | 90,06k | Derivative Exercise and Sale | 19,08 - 28,09 | 105,21k | - |
| 2026-02-20 | Dr. Eric M. DubePresident, CEO & Director | -60,00k | 878,17k | Derivative Exercise and Sale | 15,46 - 30,10 | 129,71k | - |
| 2026-02-17 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10,00k | 87,52k | Derivative Exercise and Sale | 19,08 - 28,26 | 105,21k | - |
| 2026-02-04 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -2,99k | 96,36k | Automatic Disposition | 32,07 - 32,74 | 105,21k | -2,77% |
| 2026-02-04 | Dr. Jula InrigChief Medical Officer | -1,78k | 57,30k | Automatic Disposition | 32,11 - 32,85 | 105,71k | -1,66% |
| 2026-02-04 | Mr. Christopher ClineCFO | -1,75k | 56,17k | Automatic Disposition | 32,14 - 32,90 | 111,23k | -1,54% |
| 2026-02-03 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -4,33k | 139,18k | Verkauf | 32,12 | 49,08k | -8,11% |
| 2026-02-03 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -7,18k | 230,46k | Verkauf | 32,12 | 108,21k | -6,22% |
| 2026-02-03 | Dr. William E. RoteChief Research Officer | -12,45k | 409,10k | Automatic Disposition | 32,87 | 55,31k | -18,37% |
| 2026-02-03 | Dr. Eric M. DubePresident, CEO & Director | -100,09k | 3,23M | Automatic Disposition | 32,06 - 32,70 | 129,71k | -43,55% |
| 2026-02-03 | Dr. Jula InrigChief Medical Officer | -6,96k | 223,43k | Verkauf | 32,12 | 107,49k | -6,08% |
| 2026-02-03 | Mr. Christopher ClineCFO | -7,24k | 232,61k | Verkauf | 32,12 | 112,97k | -6,02% |
| 2026-02-03 | Mr. Peter HeermaChief Commercial Officer | -7,31k | 234,80k | Verkauf | 32,12 | 72,02k | -9,22% |
| 2026-01-23 | Dr. Eric M. DubePresident, CEO & Director | -60,00k | 877,53k | Derivative Exercise and Sale | 15,46 - 30,10 | 129,71k | - |
| 2026-01-20 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10,00k | 82,62k | Derivative Exercise and Sale | 19,08 - 27,34 | 90,27k | - |
| 2026-01-05 | Dr. Jula InrigChief Medical Officer | -2,03k | 81,61k | Verkauf | 40,18 | 86,31k | -2,30% |
| 2026-01-06 | Dr. Jula InrigChief Medical Officer | -445,00 | 16,80k | Automatic Disposition | 37,75 | 86,31k | -0,51% |
| 2025-12-24 | Mr. Peter HeermaChief Commercial Officer | -4,98k | 199,20k | Automatic Disposition | 40,00 | 65,64k | -7,05% |
| 2025-12-24 | Dr. William E. RoteChief Research Officer | -60,00k | 1,17M | Derivative Exercise and Sale | 20,61 - 40,10 | 48,61k | - |
| 2025-12-24 | Dr. Jula InrigChief Medical Officer | -15,00k | 496,05k | Derivative Exercise and Sale | 8,93 - 42,00 | 88,79k | - |
| 2025-12-24 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -7,40k | 296,08k | Automatic Disposition | 40,00 | 38,23k | -16,22% |
| 2025-12-15 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -2,91k | 104,76k | Automatic Disposition | 36,00 | 45,64k | -5,99% |
| 2025-12-01 | Mr. Christopher ClineCFO | -20,00k | 375,60k | Derivative Exercise and Sale | 16,23 - 35,01 | 92,08k | - |
| 2025-11-04 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -61,25k | 733,79k | Derivative Exercise and Sale | 8,93 - 36,00 | 48,55k | - |
| 2025-11-04 | Ms. Sandra CalvinSVP, Corporate Controller & CAO | -5,87k | 211,14k | Automatic Disposition | 36,00 | 48,55k | -10,78% |
| 2025-10-31 | Mr. Timothy P. CoughlinIndependent Director | -18,00k | 325,56k | Derivative Exercise and Sale | 16,33 - 35,03 | 55,50k | - |
| 2025-10-31 | Mr. Peter HeermaChief Commercial Officer | -5,59k | 195,69k | Automatic Disposition | 35,00 | 70,62k | -7,34% |
| 2025-11-03 | Mr. Peter HeermaChief Commercial Officer | -1,08k | 0,00 | Other Disposition | - | 70,62k | -1,50% |
| 2025-10-28 | Dr. Eric M. DubePresident, CEO & Director | -120,00k | 1,78M | Derivative Exercise and Sale | 15,46 - 30,38 | 129,71k | - |
| 2025-10-28 | Mr. Peter HeermaChief Commercial Officer | -2,66k | 79,86k | Automatic Disposition | 30,00 | 77,29k | -3,33% |
| 2025-09-22 | Ms. Elizabeth E. ReedChief Legal Officer, General Counsel & Secretary | -10,00k | 59,20k | Derivative Exercise and Sale | 19,08 - 25,00 | 89,88k | - |
| 2025-09-23 | Mr. Peter HeermaChief Commercial Officer | -891,00 | 0,00 | Other Disposition | - | 79,95k | -1,10% |
| 2025-09-03 | Mr. Christopher ClineCFO | -454,00 | 8,26k | Verkauf | 18,20 | 92,08k | -0,49% |
| 2025-09-04 | Mr. Christopher ClineCFO | -119,00 | 2,35k | Automatic Disposition | 19,71 | 92,08k | -0,13% |
| 2025-08-27 | Mr. Christopher ClineCFO | -470,00 | 8,14k | Automatic Disposition | 17,31 | 92,66k | -0,50% |
| 2025-07-01 | Dr. Jula InrigChief Medical Officer | -815,00 | 11,94k | Automatic Disposition | 14,65 | 88,79k | -0,91% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
